Measuring the Incidence of Hospital Readmissions Based on Adverse Drug Events
- Conditions
- Incidence of ReadmissionsADE's Due to Anticoagulants
- Registration Number
- NCT02074085
- Lead Sponsor
- Hasselt University
- Brief Summary
An ADE is defined as harm caused by a drug or the inappropriate use of a drug. Retrospective record reviews in several countries have shown that anticoagulants frequently lead to hospital readmissions. In this study a hospital readmission is defined as an admission to the emergency department of the Jessa hospital. The objective of this study is to determine the incidence of one week and 30-day readmissions caused by (preventable) ADE's due to anticoagulants.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 450
Inclusion Criteria
- Patients who received an anticoagulant on their last day of admission
- Patients who were readmitted within 30 days
- Patients who were diagnosed using the pathology registration of the emergency department of the Jessa hospital
Exclusion Criteria
- Patients who didn't receive an anticoagulant on their last day of admission
- Patients who were not readmitted within 30 days
- Patients who were not diagnosed using the pathology registration of the emergency department of the Jessa hospital
- Patients with missing data
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method incidence of readmissions within 30 days caused by ADE's due to anticoagulants up to 1 month incidence of preventable ADE's leading to readmission week 1, month 1 incidence of readmissions within one week caused by ADE's due to anticoagulants up to one week
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Jessa Ziekenhuis
🇧🇪Hasselt, Belgium